Saratov JOURNAL of Medical and Scientific Research

Surgical method for prevention of scaring in conducting sinustrabeculectomy

Year: 2017, volume 13 Issue: №2 Pages: 372-375
Heading: Ophtalmology Article type: Original article
Authors: Zhuravleva A.N., Suleiman Е.А., Kiseleva О.А.
Organization: Moscow Helmholtz Research Institute of Eye Diseases

Prolonged hypotensive effect in the postoperative period is one of the main tasks of modern glaucoma surgery. In connection with this, the aim of our study is to develop a surgical method of prevention of scarring during the classical sinustrabeculectomy. Material and Methods. The operation was performed in 13 patients (13 eyes) with primary open angle glaucoma (POAG) ll-lll (B-C) in steps aged 50-70 years. The duration of observation up of 2 year. Results. After 9-12 months of hypotensive efficacy was 100% (13 eyes) in 20-24 months — 98% (12 of 13 eyes). The result was confirmed using standard methods of examination (visometry, tonometry, computerized perimetry, tonography et al.), in the early postoperative period was performed optical coherence tomography of the anterior segment, then — ultrasound biomicroscopy. Conclusions. Developed a new version of the surgical treatment of glaucoma a long-acting hypotensive effect.

1. Neroev VV. Separate results of the 2011 glaucoma epidemiological study. Ophthalmic records 2014; 7 (2): 4-8
2. Astahov US, Egorov ЕА, Astahov SU. Surgical treatment of "refractory" glaucoma. Clinical Ophthalmology 2006; 7 (1): 25-7
3. Francis ВА. Ab interno trabeculectomy: development of a novel device (Trabectome) and surgery for open-angle glaucoma. J Glaucoma 2006; 15 (1): 68-73
4. Crowston JG. Evaluating clinical signs in trabeculectomized eyes. Eye 2004; 18 (3): 299-303
5. Erichev VP. Refractory glaucoma: treatment options. Vestnik oftalmologii 2000; 116 (5): 8-10
6. Saheb Н, Ahmed IK. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 2012; 23 (2): 96-104
7. Kiseleva OA, et al. The way of surgical treatment of glaucoma: Patent RF, № 2603295; 2016.

2017_02-1_372-375.pdf721.89 KB

No votes yet